Understanding the Immunological Challenges of Diabetes in the Context of COVID-19

Kevin interviews Colleen Cutcliffe, CEO and Co-Founder of Pendulum. Pendulum produces a novel strain probiotic that restores the body's natural ability to metabolize fiber and produce butyrate. Kevin talks about his results with the probiotics using a continuous glucose monitor. A recent study of Pendulum demonstrated a significant reduction in A1C and blood sugar spikes in people with type 2 diabetes. The study was a U.S. based, multi-site, double-blinded, placebo controlled RCT.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.kevinrose.com